2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH

The present invention provides triazolone compounds compounds of general formula (I) : in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said c...

Full description

Saved in:
Bibliographic Details
Main Authors GRADL, STEFAN NIKOLAUS, KROBER, MICHAEL, ZIMMERMANN, KATJA, EIS, KNUT, SHEIKH, SHERIF EL, STELLFELD, TIMO, MUELLER, THOMAS, LIU, KERY, FERRARA, STEVEN JAMES, NIEHUES, MICHAEL, NGUYEN, DUY, MERZ, CLAUDIA, NISING, CARL FRIEDRICH, ZHOU, HAN JIE, GUNTHER, JUDITH, JANZER, ANDREAS, SYKES, DAVID BRIAN, ZHAO, CHANGJIA, SCHAFER, MARTINA, CHRISTIAN, SVEN
Format Patent
LanguageEnglish
French
Published 03.05.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides triazolone compounds compounds of general formula (I) : in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients. La présente invention concerne des composés triazolone de formule générale (I) : dans laquelle R1, R2, R3, R4 et R5 sont tels que définis dans la description. L'invention concerne également des procédés de préparation desdits composés, des composés intermédiaires utiles pour préparer lesdits composés, des compositions et combinaisons pharmaceutiques comprenant lesdits composés et l'utilisation desdits composés pour fabriquer des compositions pharmaceutiques pour le traitement ou la prophylaxie de maladies, en particulier de maladies hyperprolifératives, en monothérapie ou en association avec d'autres principes actifs.
Bibliography:Application Number: CA20173041643